Type 2 & other diabetes

Socioeconomic Factors and Initiation of Semaglutide or Tirzepatide Among Medicare Beneficiaries With Type 2 Diabetes

Diabetes CarePublished Cross-sectional study

Authors' conclusion

Minoritized racial and ethnic identity and adverse socioeconomic factors were associated with lower odds of initiation among Medicare beneficiaries with T2DM.

Study context

Population
Medicare beneficiaries ≥65 years with T2D
Participants
13,922,387 beneficiaries
Exposure
Socioeconomic exposures and initiation of semaglutide or tirzepatide
Outcome
Initiation of semaglutide or tirzepatide
Follow-up
2023
Methodological details100% of Medicare claims
  • 100% of Medicare claims

Main finding

As reported in the abstract

Adjusted odds ratio (95% CI)
Non-Hispanic Blackvs White
0.72(0.71–0.72)
Dual enrollment
0.90(0.89–0.91)
Most vulnerable neighborhoodsvs Least vulnerable neighborhoods
0.93(0.92–0.93)
Initiated semaglutide or tirzepatide
673,776 (4.8%)

Observational data: associations, not effects.

Original publication

Socioeconomic Factors and Initiation of Semaglutide or Tirzepatide Among Medicare Beneficiaries With Type 2 Diabetes. Diabetes Care. Published 5 December 2025. doi:10.2337/dc25-1619

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.